Cargando…
SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages
BACKGROUND: The activation of tumour-associated macrophages (TAMs) contributes to the progression of hepatocellular carcinoma (HCC). SIRT4 acts as a tumour suppressor of tumour growth by regulating cell metabolism, inflammation, and anti-tumourigenesis. However, the involvement of SIRT4 in the activ...
Autores principales: | Li, Zhi, Li, He, Zhao, Zhi-Bo, Zhu, Wei, Feng, Pan-Pan, Zhu, Xi-Wen, Gong, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862746/ https://www.ncbi.nlm.nih.gov/pubmed/31744516 http://dx.doi.org/10.1186/s13046-019-1456-9 |
Ejemplares similares
-
PAK1 Silencing Attenuated Proinflammatory Macrophage Activation and Foam Cell Formation by Increasing PPARγ Expression
por: Cheng, Wen-Lin, et al.
Publicado: (2021) -
Lysosome-Dependent LXR and PPARδ Activation Upon Efferocytosis in Human Macrophages
por: Mota, Ana Carolina, et al.
Publicado: (2021) -
Intestinal dysbacteriosis-induced IL-25 promotes development of HCC via alternative activation of macrophages in tumor microenvironment
por: Li, Qiao, et al.
Publicado: (2019) -
Bergenin, Acting as an Agonist of PPARγ, Ameliorates Experimental Colitis in Mice through Improving Expression of SIRT1, and Therefore Inhibiting NF-κB-Mediated Macrophage Activation
por: Wang, Kai, et al.
Publicado: (2018) -
Macrophages, PPARs, and Cancer
por: Van Ginderachter, Jo A., et al.
Publicado: (2008)